Metronidazole vs placebo
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Metronidazole showed no clear difference in proportion of participants with adverse event compared with placebo (high certainty).
Metronidazole probably leads to higher physician‐assessed improvement in rosacea severity compared with placebo (moderate certainty).
Metronidazole probably leads to lower duration of remission compared with placebo (moderate certainty).